Gilberto Fisone - Publications

Neuroscience Karolinska Institute, Stockholm, Sweden 

108 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Onimus O, Valjent E, Fisone G, Gangarossa G. Haloperidol-Induced Immediate Early Genes in Striatopallidal Neurons Requires the Converging Action of cAMP/PKA/DARPP-32 and mTOR Pathways. International Journal of Molecular Sciences. 23. PMID 36232936 DOI: 10.3390/ijms231911637  0.373
2022 Korchynska S, Rebernik P, Pende M, Boi L, Alpár A, Tasan R, Becker K, Balueva K, Saghafi S, Wulff P, Horvath TL, Fisone G, Dodt HU, Hökfelt T, Harkany T, et al. A hypothalamic dopamine locus for psychostimulant-induced hyperlocomotion in mice. Nature Communications. 13: 5944. PMID 36209152 DOI: 10.1038/s41467-022-33584-3  0.325
2022 Smedler E, Louhivuori L, Romanov RA, Masini D, Dehnisch Ellström I, Wang C, Caramia M, West Z, Zhang S, Rebellato P, Malmersjö S, Brusini I, Kanatani S, Fisone G, Harkany T, et al. Disrupted gene expression perturbs spontaneous Ca activity causing abnormal brain development and increased anxiety. Proceedings of the National Academy of Sciences of the United States of America. 119. PMID 35135875 DOI: 10.1073/pnas.2108768119  0.746
2021 Masini D, Plewnia C, Bertho M, Scalbert N, Caggiano V, Fisone G. A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson's Disease for the Study of Non-Motor Symptoms. Biomedicines. 9. PMID 34070345 DOI: 10.3390/biomedicines9060598  0.789
2020 Zattoni M, Garrovo C, Xerxa E, Spigolon G, Fisone G, Kristensson K, Legname G. NMDA Receptor and L-Type Calcium Channel Modulate Prion Formation. Cellular and Molecular Neurobiology. PMID 32239389 DOI: 10.1007/S10571-020-00834-1  0.336
2020 Plewnia C, Masini D, Fisone G. P.327 Non-motor complications induced by dopamine replacement therapy in a mouse model of Parkinson's disease European Neuropsychopharmacology. 31: S67. DOI: 10.1016/J.Euroneuro.2019.12.090  0.784
2019 Medeiros DC, Lopes Aguiar C, Moraes MFD, Fisone G. Sleep Disorders in Rodent Models of Parkinson's Disease. Frontiers in Pharmacology. 10: 1414. PMID 31827439 DOI: 10.3389/Fphar.2019.01414  0.381
2019 Falconi A, Bonito-Oliva A, Di Bartolomeo M, Massimini M, Fattapposta F, Locuratolo N, Dainese E, Pascale E, Fisone G, D'Addario C. On the Role of Adenosine A2A Receptor Gene Transcriptional Regulation in Parkinson's Disease. Frontiers in Neuroscience. 13: 683. PMID 31354407 DOI: 10.3389/Fnins.2019.00683  0.386
2019 Adem A, Madjid N, Stiedl O, Bonito-Oliva A, Konradsson-Geuken Å, Holst S, Fisone G, Ögren SO. Atypical but not typical antipsychotic drugs ameliorate phencyclidine-induced emotional memory impairments in mice. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30910381 DOI: 10.1016/J.Euroneuro.2019.03.007  0.332
2018 Stagkourakis S, Spigolon G, Williams P, Protzmann J, Fisone G, Broberger C. A neural network for intermale aggression to establish social hierarchy. Nature Neuroscience. 21: 834-842. PMID 29802391 DOI: 10.1038/S41593-018-0153-X  0.64
2018 Masini D, Bonito-Oliva A, Bertho M, Fisone G. Inhibition of mTORC1 Signaling Reverts Cognitive and Affective Deficits in a Mouse Model of Parkinson's Disease. Frontiers in Neurology. 9: 208. PMID 29686643 DOI: 10.3389/Fneur.2018.00208  0.788
2018 Spigolon G, Fisone G. Signal transduction in L-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 29396608 DOI: 10.1007/S00702-018-1847-7  0.465
2018 Caggiano V, Leiras R, Goñi-Erro H, Masini D, Bellardita C, Bouvier J, Caldeira V, Fisone G, Kiehn O. Midbrain circuits that set locomotor speed and gait selection. Nature. PMID 29342142 DOI: 10.1038/Nature25448  0.757
2017 Spigolon G, Cavaccini A, Trusel M, Tonini R, Fisone G. cJun N-terminal kinase (JNK) mediates cortico-striatal signaling in a model of Parkinson's disease. Neurobiology of Disease. PMID 29107639 DOI: 10.1016/J.Nbd.2017.10.015  0.526
2017 Ketzef M, Spigolon G, Johansson Y, Bonito-Oliva A, Fisone G, Silberberg G. Dopamine Depletion Impairs Bilateral Sensory Processing in the Striatum in a Pathway-Dependent Manner. Neuron. 94: 855-865.e5. PMID 28521136 DOI: 10.1016/J.Neuron.2017.05.004  0.451
2017 di Val Cervo PR, Romanov RA, Spigolon G, Masini D, Martín-Montañez E, Toledo EM, La Manno G, Feyder M, Pifl C, Ng YH, Sánchez SP, Linnarsson S, Wernig M, Harkany T, Fisone G, et al. Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model. Nature Biotechnology. PMID 28398344 DOI: 10.1038/Nbt.3835  0.777
2017 Masini D, Lopes-Aguiar C, Bonito-Oliva A, Papadia D, Andersson R, Fisahn A, Fisone G. The histamine H3 receptor antagonist thioperamide rescues circadian rhythm and memory function in experimental parkinsonism. Translational Psychiatry. 7. PMID 28398338 DOI: 10.1038/Tp.2017.58  0.752
2016 Carta AR, Mulas G, Bortolanza M, Duarte T, Pillai E, Fisone G, Vozari Raisman R, Del Bel E. L-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role? The European Journal of Neuroscience. PMID 27859864 DOI: 10.1111/Ejn.13482  0.406
2016 Bonito-Oliva A, Södersten E, Spigolon G, Hu X, Hellysaz A, Falconi A, Gomes AL, Broberger C, Hansen K, Fisone G. Differential Regulation of the Phosphorylation of Trimethyl-lysine27 Histone H3 at Serine 28 in Distinct Populations of Striatal Projection Neurons. Neuropharmacology. PMID 26947946 DOI: 10.1016/J.Neuropharm.2016.02.037  0.676
2015 Bonito-Oliva A, DuPont C, Madjid N, Ögren SO, Fisone G. Involvement of the Striatal Medium Spiny Neurons of the Direct Pathway in the Motor Stimulant Effects of Phencyclidine. The International Journal of Neuropsychopharmacology. PMID 26657176 DOI: 10.1093/Ijnp/Pyv134  0.465
2015 Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology. PMID 26209473 DOI: 10.1016/J.Pneurobio.2015.07.002  0.366
2014 Fuxe K, Borroto-Escuela D, Fisone G, Agnati LF, Tanganelli S. Understanding the role of heteroreceptor complexes in the central nervous system. Current Protein & Peptide Science. 15: 647. PMID 25256022 DOI: 10.2174/138920371507140916122738  0.358
2014 Södersten E, Feyder M, Lerdrup M, Gomes AL, Kryh H, Spigolon G, Caboche J, Fisone G, Hansen K. Dopamine signaling leads to loss of Polycomb repression and aberrant gene activation in experimental parkinsonism. Plos Genetics. 10: e1004574. PMID 25254549 DOI: 10.1371/Journal.Pgen.1004574  0.445
2014 Bonito-Oliva A, Masini D, Fisone G. A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions. Frontiers in Behavioral Neuroscience. 8: 290. PMID 25221486 DOI: 10.3389/Fnbeh.2014.00290  0.796
2014 Feyder M, Södersten E, Santini E, Vialou V, LaPlant Q, Watts EL, Spigolon G, Hansen K, Caboche J, Nestler EJ, Fisone G. A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ∆FosB Expression. Biological Psychiatry. PMID 25193242 DOI: 10.1016/J.Biopsych.2014.07.019  0.388
2014 Mango D, Bonito-Oliva A, Ledonne A, Cappellacci L, Petrelli R, Nisticò R, Berretta N, Fisone G, Mercuri NB. Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice. Experimental Neurology. 261: 733-43. PMID 25173217 DOI: 10.1016/J.Expneurol.2014.08.022  0.442
2014 Mango D, Bonito-Oliva A, Ledonne A, Nisticò R, Castelli V, Giorgi M, Sancesario G, Fisone G, Berretta N, Mercuri NB. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions. Neuropharmacology. 76: 127-36. PMID 23973317 DOI: 10.1016/J.Neuropharm.2013.08.010  0.452
2014 Bonito-Oliva A, Pignatelli M, Spigolon G, Yoshitake T, Seiler S, Longo F, Piccinin S, Kehr J, Mercuri NB, Nisticò R, Fisone G. Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism. Biological Psychiatry. 75: 701-10. PMID 23541633 DOI: 10.1016/J.Biopsych.2013.02.015  0.373
2013 Solari N, Bonito-Oliva A, Fisone G, Brambilla R. Understanding cognitive deficits in Parkinson's disease: lessons from preclinical animal models. Learning & Memory (Cold Spring Harbor, N.Y.). 20: 592-600. PMID 24049188 DOI: 10.1101/Lm.032029.113  0.389
2013 Dupuis JP, Feyder M, Miguelez C, Garcia L, Morin S, Choquet D, Hosy E, Bezard E, Fisone G, Bioulac BH, Baufreton J. Dopamine-dependent long-term depression at subthalamo-nigral synapses is lost in experimental parkinsonism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 14331-41. PMID 24005286 DOI: 10.1523/Jneurosci.1681-13.2013  0.472
2013 Allard EK, Grujic M, Fisone G, Kristensson K. Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1. Neurobiology of Disease. 58: 116-22. PMID 23742760 DOI: 10.1016/J.Nbd.2013.05.014  0.369
2013 Bonito-Oliva A, Pallottino S, Bertran-Gonzalez J, Girault JA, Valjent E, Fisone G. Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1. Neuropharmacology. 72: 197-203. PMID 23643747 DOI: 10.1016/J.Neuropharm.2013.04.043  0.469
2013 Amalric M, Lopez S, Goudet C, Fisone G, Battaglia G, Nicoletti F, Pin JP, Acher FC. Group III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease. Neuropharmacology. 66: 53-64. PMID 22664304 DOI: 10.1016/J.Neuropharm.2012.05.026  0.434
2013 Dell'anno MT, Pallottino S, Fisone G. mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neurons. Neuropharmacology. 66: 179-86. PMID 22507666 DOI: 10.1016/J.Neuropharm.2012.03.025  0.777
2012 Carta AR, Giuffrida A, Fisone G. Dyskinesia in Parkinson's disease therapy. Parkinson's Disease. 2012: 639080. PMID 23304638 DOI: 10.1155/2012/639080  0.382
2012 Fisone G, Brambilla R. Neuronal signaling and behavior. Frontiers in Behavioral Neuroscience. 6: 72. PMID 23129996 DOI: 10.3389/Fnbeh.2012.00072  0.414
2012 Santini E, Feyder M, Gangarossa G, Bateup HS, Greengard P, Fisone G. Dopamine- and cAMP-regulated phosphoprotein of 32-kDa (DARPP-32)-dependent activation of extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin complex 1 (mTORC1) signaling in experimental parkinsonism. The Journal of Biological Chemistry. 287: 27806-12. PMID 22753408 DOI: 10.1074/Jbc.M112.388413  0.461
2011 Lopez S, Bonito-Oliva A, Pallottino S, Acher F, Fisone G. Activation of metabotropic glutamate 4 receptors decreases L-DOPA-induced dyskinesia in a mouse model of Parkinson's disease. Journal of Parkinson's Disease. 1: 339-46. PMID 23939343 DOI: 10.3233/Jpd-2011-11066  0.412
2011 Feyder M, Bonito-Oliva A, Fisone G. L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission. Frontiers in Behavioral Neuroscience. 5: 71. PMID 22028687 DOI: 10.3389/Fnbeh.2011.00071  0.511
2011 Errico F, Bonito-Oliva A, Bagetta V, Vitucci D, Romano R, Zianni E, Napolitano F, Marinucci S, Di Luca M, Calabresi P, Fisone G, Carta M, Picconi B, Gardoni F, Usiello A. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia. Experimental Neurology. 232: 240-50. PMID 21946266 DOI: 10.1016/J.Expneurol.2011.09.013  0.414
2011 Fisone G, Bezard E. Molecular mechanisms of l-DOPA-induced dyskinesia. International Review of Neurobiology. 98: 95-122. PMID 21907084 DOI: 10.1016/B978-0-12-381328-2.00004-3  0.411
2011 Valjent E, Bertran-Gonzalez J, Bowling H, Lopez S, Santini E, Matamales M, Bonito-Oliva A, Hervé D, Hoeffer C, Klann E, Girault JA, Fisone G. Haloperidol regulates the state of phosphorylation of ribosomal protein S6 via activation of PKA and phosphorylation of DARPP-32. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 2561-70. PMID 21814187 DOI: 10.1038/Npp.2011.144  0.462
2011 Bonito-Oliva A, Feyder M, Fisone G. Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling. Frontiers in Neuroanatomy. 5: 38. PMID 21808606 DOI: 10.3389/Fnana.2011.00038  0.502
2011 Gangarossa G, Di Benedetto M, O'Sullivan GJ, Dunleavy M, Alcacer C, Bonito-Oliva A, Henshall DC, Waddington JL, Valjent E, Fisone G. Convulsant doses of a dopamine D1 receptor agonist result in Erk-dependent increases in Zif268 and Arc/Arg3.1 expression in mouse dentate gyrus. Plos One. 6: e19415. PMID 21559295 DOI: 10.1371/Journal.Pone.0019415  0.441
2010 Santini E, Sgambato-Faure V, Li Q, Savasta M, Dovero S, Fisone G, Bezard E. Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia. Plos One. 5: e12322. PMID 20808799 DOI: 10.1371/Journal.Pone.0012322  0.41
2010 Bateup HS, Santini E, Shen W, Birnbaum S, Valjent E, Surmeier DJ, Fisone G, Nestler EJ, Greengard P. Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proceedings of the National Academy of Sciences of the United States of America. 107: 14845-50. PMID 20682746 DOI: 10.1073/Pnas.1009874107  0.46
2010 Santini E, Valjent E, Fisone G. mTORC1 signaling in Parkinson's disease and L-DOPA-induced dyskinesia: A sensitized matter. Cell Cycle (Georgetown, Tex.). 9: 2713-8. PMID 20581466 DOI: 10.4161/Cc.9.14.12323  0.482
2010 Napolitano F, Pasqualetti M, Usiello A, Santini E, Pacini G, Sciamanna G, Errico F, Tassone A, Di Dato V, Martella G, Cuomo D, Fisone G, Bernardi G, Mandolesi G, Mercuri NB, et al. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. Neurobiology of Disease. 38: 434-45. PMID 20227500 DOI: 10.1016/J.Nbd.2010.03.003  0.428
2009 Valjent E, Bertran-Gonzalez J, Hervé D, Fisone G, Girault JA. Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice. Trends in Neurosciences. 32: 538-47. PMID 19765834 DOI: 10.1016/J.Tins.2009.06.005  0.397
2009 Santini E, Heiman M, Greengard P, Valjent E, Fisone G. Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia. Science Signaling. 2: ra36. PMID 19622833 DOI: 10.1126/Scisignal.2000308  0.47
2009 Santini E, Alcacer C, Cacciatore S, Heiman M, Hervé D, Greengard P, Girault JA, Valjent E, Fisone G. L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice. Journal of Neurochemistry. 108: 621-33. PMID 19187092 DOI: 10.1111/J.1471-4159.2008.05831.X  0.472
2009 Bertran-Gonzalez J, Håkansson K, Borgkvist A, Irinopoulou T, Brami-Cherrier K, Usiello A, Greengard P, Hervé D, Girault JA, Valjent E, Fisone G. Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1710-20. PMID 19158668 DOI: 10.1038/Npp.2008.228  0.45
2009 Nordström E, Fisone G, Kristensson K. Opposing effects of ERK and p38-JNK MAP kinase pathways on formation of prions in GT1-1 cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 613-22. PMID 18824519 DOI: 10.1096/Fj.08-115360  0.351
2008 Errico F, Rossi S, Napolitano F, Catuogno V, Topo E, Fisone G, D'Aniello A, Centonze D, Usiello A. D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 10404-14. PMID 18842900 DOI: 10.1523/Jneurosci.1618-08.2008  0.319
2008 Westerlund M, Ran C, Borgkvist A, Sterky FH, Lindqvist E, Lundströmer K, Pernold K, Brené S, Kallunki P, Fisone G, Olson L, Galter D. Lrrk2 and alpha-synuclein are co-regulated in rodent striatum. Molecular and Cellular Neurosciences. 39: 586-91. PMID 18790059 DOI: 10.1016/J.Mcn.2008.08.001  0.372
2008 Korhonen L, Hansson I, Maugras C, Wehrle R, Kairisalo M, Borgkvist A, Jokitalo E, Sotelo C, Fisone G, Dusart I, Lindholm D. Expression of X-chromosome linked inhibitor of apoptosis protein in mature Purkinje cells and in retinal bipolar cells in transgenic mice induces neurodegeneration. Neuroscience. 156: 515-26. PMID 18765270 DOI: 10.1016/J.Neuroscience.2008.08.005  0.304
2008 Borgkvist A, Valjent E, Santini E, Hervé D, Girault JA, Fisone G. Delayed, context- and dopamine D1 receptor-dependent activation of ERK in morphine-sensitized mice. Neuropharmacology. 55: 230-7. PMID 18614186 DOI: 10.1016/J.Neuropharm.2008.05.028  0.412
2008 O'Sullivan GJ, Dunleavy M, Hakansson K, Clementi M, Kinsella A, Croke DT, Drago J, Fienberg AA, Greengard P, Sibley DR, Fisone G, Henshall DC, Waddington JL. Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling. Neuropharmacology. 54: 1051-61. PMID 18367215 DOI: 10.1016/J.Neuropharm.2008.02.011  0.336
2008 Santini E, Valjent E, Fisone G. Parkinson's disease: levodopa-induced dyskinesia and signal transduction. The Febs Journal. 275: 1392-9. PMID 18279379 DOI: 10.1111/J.1742-4658.2008.06296.X  0.497
2008 Marcellino D, Carriba P, Filip M, Borgkvist A, Frankowska M, Bellido I, Tanganelli S, Müller CE, Fisone G, Lluis C, Agnati LF, Franco R, Fuxe K. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology. 54: 815-23. PMID 18262573 DOI: 10.1016/J.Neuropharm.2007.12.011  0.353
2008 Errico F, Santini E, Migliarini S, Borgkvist A, Centonze D, Nasti V, Carta M, De Chiara V, Prosperetti C, Spano D, Herve D, Pasqualetti M, Di Lauro R, Fisone G, Usiello A. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Molecular and Cellular Neurosciences. 37: 335-45. PMID 18035555 DOI: 10.1016/J.Mcn.2007.10.007  0.471
2008 Borgkvist A, Marcellino D, Fuxe K, Greengard P, Fisone G. Regulation of DARPP-32 phosphorylation by Delta9-tetrahydrocannabinol. Neuropharmacology. 54: 31-5. PMID 17686497 DOI: 10.1016/J.Neuropharm.2007.06.025  0.484
2007 Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferré S. Adenosine A2A receptors and basal ganglia physiology. Progress in Neurobiology. 83: 277-92. PMID 17646043 DOI: 10.1016/J.Pneurobio.2007.05.001  0.411
2007 Santini E, Valjent E, Usiello A, Carta M, Borgkvist A, Girault JA, Hervé D, Greengard P, Fisone G. Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 6995-7005. PMID 17596448 DOI: 10.1523/Jneurosci.0852-07.2007  0.434
2007 Fisone G, Håkansson K, Borgkvist A, Santini E. Signaling in the basal ganglia: postsynaptic and presynaptic mechanisms. Physiology & Behavior. 92: 8-14. PMID 17585965 DOI: 10.1016/J.Physbeh.2007.05.028  0.468
2007 Borgkvist A, Usiello A, Greengard P, Fisone G. Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1995-2003. PMID 17251906 DOI: 10.1038/Sj.Npp.1301321  0.42
2007 Borgkvist A, Fisone G. Psychoactive drugs and regulation of the cAMP/PKA/DARPP-32 cascade in striatal medium spiny neurons. Neuroscience and Biobehavioral Reviews. 31: 79-88. PMID 16730373 DOI: 10.1016/J.Neubiorev.2006.03.003  0.447
2006 Håkansson K, Galdi S, Hendrick J, Snyder G, Greengard P, Fisone G. Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors. Journal of Neurochemistry. 96: 482-8. PMID 16336634 DOI: 10.1111/J.1471-4159.2005.03558.X  0.468
2006 Borgkvist A, Puelles E, Carta M, Acampora D, Ang SL, Wurst W, Goiny M, Fisone G, Simeone A, Usiello A. Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice. Molecular and Cellular Neurosciences. 31: 293-302. PMID 16256364 DOI: 10.1016/J.Mcn.2005.09.018  0.45
2005 Andersson M, Usiello A, Borgkvist A, Pozzi L, Dominguez C, Fienberg AA, Svenningsson P, Fredholm BB, Borrelli E, Greengard P, Fisone G. Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 8432-8. PMID 16162925 DOI: 10.1523/Jneurosci.1289-05.2005  0.757
2005 Lundblad M, Usiello A, Carta M, HÃ¥kansson K, Fisone G, Cenci MA. Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia. Experimental Neurology. 194: 66-75. PMID 15899244 DOI: 10.1016/J.Expneurol.2005.02.002  0.392
2005 Guigoni C, Aubert I, Li Q, Gurevich VV, Benovic JL, Ferry S, Mach U, Stark H, Leriche L, HÃ¥kansson K, Bioulac BH, Gross CE, Sokoloff P, Fisone G, Gurevich EV, et al. Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors. Parkinsonism & Related Disorders. 11: S25-9. PMID 15885624 DOI: 10.1016/J.Parkreldis.2004.11.005  0.428
2005 Aubert I, Guigoni C, HÃ¥kansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Annals of Neurology. 57: 17-26. PMID 15514976 DOI: 10.1002/Ana.20296  0.43
2004 Nairn AC, Svenningsson P, Nishi A, Fisone G, Girault JA, Greengard P. The role of DARPP-32 in the actions of drugs of abuse. Neuropharmacology. 47: 14-23. PMID 15464122 DOI: 10.1016/J.Neuropharm.2004.05.010  0.385
2004 Håkansson K, Pozzi L, Usiello A, Haycock J, Borrelli E, Fisone G. Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol European Journal of Neuroscience. 20: 1108-1112. PMID 15305880 DOI: 10.1111/J.1460-9568.2004.03547.X  0.745
2004 Håkansson K, Lindskog M, Pozzi L, Usiello A, Fisone G. DARPP-32 and modulation of cAMP signaling: Involvement in motor control and levodopa-induced dyskinesia Parkinsonism and Related Disorders. 10: 281-286. PMID 15196506 DOI: 10.1016/J.Parkreldis.2004.02.010  0.752
2004 Fisone G, Borgkvist A, Usiello A. Caffeine as a psychomotor stimulant: mechanism of action. Cellular and Molecular Life Sciences : Cmls. 61: 857-72. PMID 15095008 DOI: 10.1007/S00018-003-3269-3  0.442
2004 Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P. DARPP-32: an integrator of neurotransmission. Annual Review of Pharmacology and Toxicology. 44: 269-96. PMID 14744247 DOI: 10.1146/Annurev.Pharmtox.44.101802.121415  0.423
2003 Collin M, Bäckberg M, Ovesjö ML, Fisone G, Edwards RH, Fujiyama F, Meister B. Plasma membrane and vesicular glutamate transporter mRNAs/proteins in hypothalamic neurons that regulate body weight. The European Journal of Neuroscience. 18: 1265-78. PMID 12956725 DOI: 10.1046/J.1460-9568.2003.02840.X  0.322
2003 Pozzi L, HÃ¥kansson K, Usiello A, Borgkvist A, Lindskog M, Greengard P, Fisone G. Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. Journal of Neurochemistry. 86: 451-9. PMID 12871586 DOI: 10.1046/J.1471-4159.2003.01851.X  0.721
2003 Picconi B, Centonze D, HÃ¥kansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, Calabresi P. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nature Neuroscience. 6: 501-6. PMID 12665799 DOI: 10.1038/Nn1040  0.387
2003 Lindgren N, Usiello A, Goiny M, Haycock J, Erbs E, Greengard P, Hokfelt T, Borrelli E, Fisone G. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proceedings of the National Academy of Sciences of the United States of America. 100: 4305-9. PMID 12651945 DOI: 10.1073/Pnas.0730708100  0.421
2002 Hökfelt T, Blacker D, Broberger C, Herrera-Marschitz M, Snyder G, Fisone G, Cortés R, Morino P, You ZB, Ogren SO. Some aspects on the anatomy and function of central cholecystokinin systems. Pharmacology & Toxicology. 91: 382-6. PMID 12688383 DOI: 10.1034/J.1600-0773.2002.910617.X  0.659
2002 Lindskog M, Svenningsson P, Pozzi L, Kim Y, Fienberg AA, Bibb JA, Fredholm BB, Nairn AC, Greengard P, Fisone G. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature. 418: 774-8. PMID 12181566 DOI: 10.1038/Nature00817  0.721
2002 Lindgren N, Goiny M, Herrera-Marschitz M, Haycock JW, Hökfelt T, Fisone G. Activation of extracellular signal-regulated kinases 1 and 2 by depolarization stimulates tyrosine hydroxylase phosphorylation and dopamine synthesis in rat brain. The European Journal of Neuroscience. 15: 769-73. PMID 11886455 DOI: 10.1046/J.1460-9568.2002.01901.X  0.44
2001 Lindgren N, Xu ZQ, Herrera-Marschitz M, Haycock J, Hökfelt T, Fisone G. Dopamine D(2) receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum. The European Journal of Neuroscience. 13: 773-80. PMID 11207812 DOI: 10.1046/J.0953-816X.2000.01443.X  0.466
2000 Svenningsson P, Fienberg AA, Allen PB, Moine CL, Lindskog M, Fisone G, Greengard P, Fredholm BB. Dopamine D(1) receptor-induced gene transcription is modulated by DARPP-32. Journal of Neurochemistry. 75: 248-57. PMID 10854268 DOI: 10.1046/J.1471-4159.2000.0750248.X  0.43
2000 Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB, Fisone G. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proceedings of the National Academy of Sciences of the United States of America. 97: 1856-60. PMID 10677546 DOI: 10.1073/Pnas.97.4.1856  0.442
1999 Nishi A, Fisone G, Snyder GL, Dulubova I, Aperia A, Nairn AC, Greengard P. Regulation of Na+, K+-ATPase isoforms in rat neostriatum by dopamine and protein kinase C. Journal of Neurochemistry. 73: 1492-501. PMID 10501194 DOI: 10.1046/J.1471-4159.1999.0731492.X  0.379
1999 Nishi A, Snyder GL, Fienberg AA, Fisone G, Aperia A, Nairn AC, Greengard P. Requirement for DARPP-32 in mediating effect of dopamine D2 receptor activation. The European Journal of Neuroscience. 11: 2589-92. PMID 10383649 DOI: 10.1046/J.1460-9568.1999.00724.X  0.424
1999 Lindskog M, Svenningsson P, Fredholm B, Greengard P, Fisone G. Mu- and delta-opioid receptor agonists inhibit DARPP-32 phosphorylation in distinct populations of striatal projection neurons. The European Journal of Neuroscience. 11: 2182-6. PMID 10336688 DOI: 10.1046/J.1460-9568.1999.00597.X  0.424
1999 Lindskog M, Svenningsson P, Fredholm BB, Greengard P, Fisone G. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms. Neuroscience. 88: 1005-8. PMID 10336115 DOI: 10.1016/S0306-4522(98)00411-4  0.444
1998 Svenningsson P, Lindskog M, Rognoni F, Fredholm BB, Greengard P, Fisone G. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience. 84: 223-8. PMID 9522376 DOI: 10.1016/S0306-4522(97)00510-1  0.48
1998 Fisone G, Snyder GL, Aperia A, Greengard P. Na+,K+-ATPase Phosphorylation in the Choroid Plexus: Synergistic Regulation by Serotonin/Protein Kinase C and Isoproterenol/cAMP-PK/PP-1 Pathways Molecular Medicine. 4: 258-265. DOI: 10.1007/Bf03401922  0.326
1995 Fisone G, Snyder GL, Fryckstedt J, Caplan MJ, Aperia A, Greengard P. Na+,K(+)-ATPase in the choroid plexus. Regulation by serotonin/protein kinase C pathway. The Journal of Biological Chemistry. 270: 2427-30. PMID 7852300 DOI: 10.1074/Jbc.270.6.2427  0.312
1994 Snyder GL, Fisone G, Greengard P. Phosphorylation of DARPP-32 is regulated by GABA in rat striatum and substantia nigra Journal of Neurochemistry. 63: 1766-1771. PMID 7931332 DOI: 10.1046/J.1471-4159.1994.63051766.X  0.371
1993 Snyder GL, Fisone G, Morino P, Gundersen V, Ottersen OP, Hökfelt T, Greengard P. Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum. Proceedings of the National Academy of Sciences of the United States of America. 90: 11277-81. PMID 8248241 DOI: 10.1073/Pnas.90.23.11277  0.449
1992 Fisone G, Bartfai T, Nilsson S, Hökfelt T. Galanin inhibits the potassium-evoked release of acetylcholine and the muscarinic receptor-mediated stimulation of phosphoinositide turnover in slices of monkey hippocampus. Brain Research. 568: 279-84. PMID 1726068 DOI: 10.1016/0006-8993(91)91409-T  0.334
1992 Amoroso D, Girotti P, Fisone G, Bartfai T, Consolo S. Mechanism of the galanin induced increase in acetylcholine release in vivo from striata of freely moving rats Brain Research. 589: 33-38. PMID 1384927 DOI: 10.1016/0006-8993(92)91158-B  0.346
1992 Bartfai T, Fisone G, Langel U. Galanin and galanin antagonists: molecular and biochemical perspectives. Trends in Pharmacological Sciences. 13: 312-7. PMID 1384214 DOI: 10.1016/0165-6147(92)90098-Q  0.344
1991 Palazzi E, Felinska S, Zambelli M, Fisone G, Bartfai T, Consolo S. Galanin reduces carbachol stimulation of phosphoinositide turnover in rat ventral hippocampus by lowering Ca2+ influx through voltage-sensitive Ca2+ channels. Journal of Neurochemistry. 56: 739-47. PMID 1704418 DOI: 10.1111/J.1471-4159.1991.Tb01986.X  0.325
1990 Fisone G, Berthold M, Bedecs K, Undén A, Bartfai T, Bertorelli R, Consolo S, Crawley J, Martin B, Nilsson S. N-terminal galanin-(1-16) fragment is an agonist at the hippocampal galanin receptor. Proceedings of the National Academy of Sciences of the United States of America. 86: 9588-91. PMID 2594786 DOI: 10.1073/Pnas.86.23.9588  0.325
1990 Consolo S, Palazzi E, Bertorelli R, Fisone G, Crawley J, Hokfelt T, Bartfai T. Functional aspects of acetylcholine-galanin coexistence in the brain. Progress in Brain Research. 84: 279-287. PMID 1702545 DOI: 10.1016/S0079-6123(08)60912-7  0.338
1990 Crawley J, Austin M, Fiske S, Martin B, Consolo S, Berthold M, Langel U, Fisone G, Bartfai T. Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus The Journal of Neuroscience. 10: 3695-3700. DOI: 10.1523/Jneurosci.10-11-03695.1990  0.301
1989 Melander T, Bartfai T, Brynne N, Consolo S, Fisone G, Hokfelt T, Kohler C, Nordstrom O, Norheim-Theodorsson E, Persson A, Sedvall G, Staines WA, Wu CF. Galanin in the cholinergic basal forebrain: histochemical, autoradiographic and in vivo studies Progress in Brain Research. 79: 85-91. PMID 2479959 DOI: 10.1016/S0079-6123(08)62467-X  0.333
1988 Tacconi MT, Fisone G, Consolo S. Modulation of phospholipid methylation in rat striatum by the corticostriatal pathway. Brain Research. 461: 194-8. PMID 3066434 DOI: 10.1016/0006-8993(88)90741-X  0.347
1987 Fisone G, Wu CF, Consolo S, Nordstrom O, Brynne N, Bartfai T, Melander T, Hokfelt T. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies Proceedings of the National Academy of Sciences of the United States of America. 84: 7339-7343. PMID 2444980 DOI: 10.1073/Pnas.84.20.7339  0.314
1986 Forloni G, Fisone G, Consolo S, Ladinsky H. Qualitative differences in the effects of adenosine analogs on the cholinergic systems of rat striatum and hippocampus Naunyn-Schmiedebergs Archives of Pharmacology. 334: 86-91. PMID 3024027 DOI: 10.1007/Bf00498744  0.398
Show low-probability matches.